Professor Colditz says the potential advantages of this type of stem cell treatment are threefold: early intervention; a high dose of stem cells; and using cells from the baby’s own supply, in the placenta.
This work by the Perinatal Research Centre has been underpinned by a technique developed by another UQ Faculty of Medicine team.
Associate Professor Kiarash Khosrotehrani and postdoctoral researcher Dr Jatin Patel were able to isolate and harvest large quantities of stem cells from the placenta.
These could then be used to create blood vessels in areas of the body lacking blood flow.
This method could now provide the key to unlocking new treatment for perinatal brain injury.
Professor Colditz says placental stem cells are more beneficial than those from the umbilical cord because of their high dose and ability to secrete pro-growth repair factors within the brain.
UQ Medicine’s placental stem cell research has the potential to save millions of dollars in healthcare costs, while transforming treatment and health outcomes for our tiniest patients.
This story is featured in the Summer 2017 edition of UQMedicine Magazine. View the latest edition here. Or to listen, watch, or read more stories from UQ’s Faculty of Medicine visit our content hub, MayneStream.